Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-COMP in cardiopathic patients with DLBCL
NCT01009970Phase 2Unknown
- Sponsor
- Fondazione Italiana Linfomi
- Start
- May 2010
- Primary completion
- May 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), sponsored by Fondazione Italiana Linfomi. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01009970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009970.